How healthcare states matter: Comparing the introduction of clinical standards in Britain and Germany

Journal of Health Organization and Management

Volumn 23, Issue 3, 2009, Pages 289-303

  Burau, Viola ^a   Fenton, Laura ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b YORK UNIVERSITY   (Canada)

Author keywords

Germany; Health services; Public sector reform; United Kingdom

Indexed keywords

EID: 70349789325     PISSN: 14777266     EISSN: None     Source Type: Journal    
DOI: 10.1108/14777260910966726     Document Type: Article

References (40)

1. Academy of Medical Royal Colleges (1999), Proposals for Revalidation, Academy of Medical Royal Colleges, London.
2. Academy of Medical Royal Colleges (Revalidation Leads Group) (2000), How the Royal Colleges and Faculties Might Contribute to the Process of Revalidation, Academy of Medical Royal Colleges, London.
3. Buchner, F. and Wasem, J. (2003), “Needs for further improvement: risk adjustment in the German health insurance system”, Health Policy, Vol. 65 No. 1, pp. 21-35.
4. Bundesärztekammer (2002), in Ed. Hoppe, J-D. (Ed.), Position der BÄK zu Disease-Management-Programmen nach §137f SGBV. Stellungnahme des Präsidenten der Bundesärztekammer, gegen über dem Bundesgesundheitsministerium vom 14 Juni, available at: www.bundesaerztekammer.de/cgi-bin/printVersion.cgi (accessed 9 September 2009).
5. Bundesministerium für Gesundheit (2001), Gesetz zur Reform des Risikostrukturausgleichs in der gesetzlichen Krankenversicherung, Vol. 10, Dezember, available at: www.bmgs.bund.de/download/gesetze/gkv/rsa/gesetzrsa.htm (accessed 9 September 2008).
6. Burau, V. (2007), “The complexity of governance change: reforming the governance of medical performance in Germany”, Health Economics, Policy and Law, Vol. 2 No. 4, pp. 391-407.
7. Burau, V. (n.d.), “The dynamics of incremental governance change: disease management programmes and the introduction of clinical standards in Germany”, Health Economics, Policy and Law, special issue (under review).
8. Burau, V. and Vrangbæk, K. (n.d.), “Institutions and non-linear change in governance: reforming the governance of medical performance in Europe”, Journal of Health Management and Organisation, special issue (forthcoming).
9. Busse, R. (2004), “Disease management programs in Germany's statutory health insurance system”, Health Affairs, Vol. 23 No. 3, pp. 56-67.
10. Busse, R. and Riesberg, A. (2004), Health Care Systems in Transition: Germany, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen.
11. Chief Medical Officer (2007), Trust, Assurance and Safety: The Regulation of Health Professionals, Department of Health, London.
12. Dent, M. (2003), Remodelling Hospitals and Health Professions in Europe. Medicine, Nursing and the State, Palgrave, Basingstoke.
13. Department of Health (1998 a), “NHS to have legal duty of ensuring quality for first time”, Press Release 98/141, Department of Health, London, 13 April.
14. Department of Health (1998 b), A First Class Service: Quality in the New NHS, Department of Health, London.
15. Döhler, M. and Manow, P. (1997), Strukturbildung von Politikfeldern. Das Beispiel bundesdeutscher Gesundheitspolitik seit den fünfziger Jahren, Leske und Budrich, Opaden.
16. Dubois, C.-A., Dixon, A. and Mc Kee, M. (2005), “Reshaping the regulation of the workforce in European health care systems”, in Ed. Dubois, C.-A., Ed. Nolte, E. and Ed. Mc Kee, M. (Eds), Human Resources for Health in Europe, Open University Press, Maidenhead.
17. Fenton, L. and Salter, B. (2009), “The clinical governance and revalidation policies in the UK: competition and compromise in negotiating the new governance of medical performance”, Health Economics, Policy and Law, special issue, Vol. 26 May, pp. 1-19.
18. General Medical Council (1995), Good Medical Practice, General Medical Council, London.
19. Gray, A. and Harrison, S. (2004), Governing Medicine. Theory and Practice, Open University Press, Maidenhead.
20. Healthcare Commission (2006), Investigation into Ten Maternal Deaths at, or Following Delivery at, Northwick Park Hospital, North West London Hospitals NHS Trust, between April 2002 and April 2005, Healthcare Commission, London.
21. Igl, G. (2002), “Rechtlicher Rahmen der Qualitätssicherung im Krankenhaus”, Zeitschrift für Sozialreform, Vol. 48 No. 4, pp. 481-493.
22. Irvine, D. (2003), The Doctor's Tale: Professionalism and Public Trust, Radcliffe Medical Press, Oxford.
23. Kuhlmann, E. (2004), Gender Mainstreaming in den Disease-Management Programmen – das Beispiel Koronare Herzerkrankungen. Expertise im Auftrag der Bundeskoordination Frauengesundheit, Zentrum für Sozialpolitik, Universität Bremen, Bremen.
24. Kuhlmann, E. (2006), Modernising Health Care. Reinventing Professions, the State and the Public, Policy Press, Bristol.
25. Mahoney, J. (2000), “Path dependence in historical sociology”, Theory and Society, Vol. 29, pp. 507-548.
26. Moran, M. (1999), Governing the Health Care State. A Comparative Study of the United Kingdom, the United States and Germany, Manchester University Press, Manchester.
27. Müller de Cornejo, G. (2005), “Disease-Management Programme in Deutschland”, Jahrbuch für Kritische Medizin, Vol. 41, pp. 20-37.
28. National Health Service Executive (1999 a), Clinical Governance: Quality in the New NHS, HSC 1999/065, National Health Service Executive, Leeds.
29. National Health Service Executive (1999 b), The NHS Performance Assessment Framework, National Health Service Executive, Leeds.
30. Rosenbrock, R. and Gerlinger, T. (2004), Gesundheitspolitik. Eine systematische Einführung, Hans Huber, Bern.
31. Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen (2001), Bedarfsgerechtigkeit und Wirtschaftlichkeit, Deutscher Bundestag, Drucksache 14-5660, 14-5661, 14-4871, Deutscher Bundestag, Berlin, Gutachten 2000/2001.
32. Salter, B. (2001), “Who rules? The new politics of medical regulation”, Social Science & Medicine, Vol. 52, pp. 871-883.
33. Salter, B. (2004), The New Politics of Medicine, Palgrave, London.
34. Salter, B. (2007), “Governing UK medical performance: a struggle for policy dominance”, Health Policy, Vol. 82, pp. 263-275.
35. Scharpf, F.W. (1997), Games Real Actors Can Play: Actor-centered Institutionalism in Policy-research, Westview Press, Boulder, CO.
36. Scott, R.W. (1995), Institutions and Organizations, Sage, Thousand Oaks, CA.
37. Shipman Inquiry (2005), Safeguarding Patients: Lessons from the Past – Proposals for the Future, Shipman Inquiry, London, 5th Report, Shipman Inquiry (Chair: Dame Janet Smith DBE), London.
38. Thelen, K. (1999), “Historical institutionalism in comparative politics”, Annual Review of Political Science, Vol. 2, pp. 369-404.
39. Urban, H.-J. (2001), “Wettbewerbskorporatistische Regulierung im Politikfeld Gesundheit. Der Bundesausschuss der Ärzte und Krankenkassen und die gesundheitspolitische Wende”, WZB discussion paper, P01-206, Wissenschaftszentrum Berlin für Sozialforschung, Berlin.
40. Wilsford, D. (1994), “Path dependency, or why history makes it difficult but not impossible to reform health care systems in a big way”, Journal of Public Policy, Vol. 14 No. 3, pp. 285-309.